Shares of Invivyd (NASDAQ:IVVD) closed 42% increased Friday after the biotech firm introduced it had obtained FDA emergency use authorization, or EUA, for its COVID-19 prophylactic drug Pemgarda and launched Part...
Whereas Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) will seemingly rule the weight problems drug marketplace for the following decade, rivals equivalent to Amgen (NASDAQ:AMGN) and Pfizer (NYSE:PFE) might quickly be...